Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.

By Nancy Y. Lee, P. Xia, J. Quivey, K. Sultanem, I. Poon, C. Akazawa, P. Akazawa, V. Weinberg, K. Fu. International Journal of Radiation Oncology, Biology, Physics, 2001

1,010 citations recorded by the source corpus.

Subfields: Otorhinolaryngology, Radiation, Surgery

View Paper: https://www.semanticscholar.org/paper/2fe3b71f84170e9ee50d31b1bc2fe7af38f2fb14

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. Y. Nikiforov

Citations in the corpus

• Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond (2005, methodology): “The initial UCSF experience with IMRT in nasopharynx cancer was published in 2002.(60) With a median follow-up of 31 months for 67 patients, the 4-year estimates of local progressionfree survival, distant-metastasis-free survival, and overall survival were 97%, 66%, and 88%, respectively.”
• American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer (2012, background): “There is strong evidence of the benefit of IMRT in improving outcome and reducing toxicity in other head and neck cancers (180,181).”